Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Hartnell

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Diabetes Technology & Therapeutics|June 29, 2023
Closed-Loop from Diagnosis of Type 1 Diabetes in Children and Young PeopleAtrayee Ghatak, Charlotte K Boughton, Janet M Allen, et al.
Journal of Diabetes Science and Technology|October 18, 2024
Impact of Ultra-Rapid Insulin on Boost and Ease-Off in the Cambridge Hybrid Closed-Loop System for Individuals With Type 1 DiabetesChloë Royston, Charlotte Boughton, Munachiso Nwokolo, et al.
Diabetes Care|March 12, 2016
Variability of Insulin Requirements Over 12 Weeks of Closed-Loop Insulin Delivery in Adults With Type 1 DiabetesYue Ruan, Hood Thabit, Lalantha Leelarathna, et al.
Diabetes Technology & Therapeutics|May 3, 2017
Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 DiabetesAli Emami, Malgorzata E Willinska, Hood Thabit, et al.
The Lancet. Healthy Longevity|April 1, 2022
Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover studyCharlotte K Boughton, Sara Hartnell, Hood Thabit, et al.
Diabetes Technology & Therapeutics|February 5, 2024
Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 DiabetesBelma Haliloglu, Charlotte K Boughton, Rama Lakshman, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover studyCharlotte K Boughton, Sara Hartnell, Hood Thabit, et al.
Diabetes, Obesity & Metabolism|March 27, 2018
Hypoglycaemia incidence and recovery during home use of hybrid closed-loop insulin delivery in adults with type 1 diabetesYue Ruan, Lia Bally, Hood Thabit, et al.
Diabetes, Obesity & Metabolism|April 4, 2017
Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetesYue Ruan, Hood Thabit, Lalantha Leelarathna, et al.
Diabetes Technology & Therapeutics|August 13, 2025
Trends in Total Daily Dose and Variability of Insulin Requirements in Newly Diagnosed Children and Adolescents with Type 1 Diabetes over 48 MonthsChloë Royston, Julia Ware, Janet M Allen, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Diabetes Technology & Therapeutics|June 29, 2023
Closed-Loop from Diagnosis of Type 1 Diabetes in Children and Young PeopleAtrayee Ghatak, Charlotte K Boughton, Janet M Allen, et al.
Journal of Diabetes Science and Technology|October 18, 2024
Impact of Ultra-Rapid Insulin on Boost and Ease-Off in the Cambridge Hybrid Closed-Loop System for Individuals With Type 1 DiabetesChloë Royston, Charlotte Boughton, Munachiso Nwokolo, et al.
Diabetes Care|March 12, 2016
Variability of Insulin Requirements Over 12 Weeks of Closed-Loop Insulin Delivery in Adults With Type 1 DiabetesYue Ruan, Hood Thabit, Lalantha Leelarathna, et al.
Diabetes Technology & Therapeutics|May 3, 2017
Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 DiabetesAli Emami, Malgorzata E Willinska, Hood Thabit, et al.
The Lancet. Healthy Longevity|April 1, 2022
Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover studyCharlotte K Boughton, Sara Hartnell, Hood Thabit, et al.
Diabetes Technology & Therapeutics|February 5, 2024
Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 DiabetesBelma Haliloglu, Charlotte K Boughton, Rama Lakshman, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover studyCharlotte K Boughton, Sara Hartnell, Hood Thabit, et al.
Diabetes, Obesity & Metabolism|March 27, 2018
Hypoglycaemia incidence and recovery during home use of hybrid closed-loop insulin delivery in adults with type 1 diabetesYue Ruan, Lia Bally, Hood Thabit, et al.
Diabetes, Obesity & Metabolism|April 4, 2017
Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetesYue Ruan, Hood Thabit, Lalantha Leelarathna, et al.
Diabetes Technology & Therapeutics|August 13, 2025
Trends in Total Daily Dose and Variability of Insulin Requirements in Newly Diagnosed Children and Adolescents with Type 1 Diabetes over 48 MonthsChloë Royston, Julia Ware, Janet M Allen, et al.
Pageof 7